'Last resort' antibiotics increasingly used to fight multidrug-resistant bugs

Multidrug-resistant pathogens are becoming more frequent, and the few "last resort" treatments available for infections with these bacteria have also shown an increase in use in recent years, according to a study published May 16 in the open access journal PLoS ONE.

The authors, led by Makoto Jones of the Veterans Affairs Salt Lake City , investigated the use of two such antibiotics, polymyxins and tigecycline, in 127 Veterans Affairs medical centers between 2005 and 2010. They found that the overall use of these treatments was quite low, but that it did increase over the course of the study period. While this is the first study assessing use of these drugs in the United States on a large scale the trend is almost certainly not limited to the VA.

They also found that just eight facilities accounted for three quarters of all polymyxin use, and 26 facilities accounted for three quarters of all tigecycline use. Dr. Jones commented "The use of polymyxins, a class of relatively toxic antibiotics, has been increasing over time and appears to be a marker of very . To address this potential harbinger of a growing epidemic, a clear strategy of infection control, antibiotic development, and antibiotic stewardship will be necessary."

More information: Huttner B, Jones M, Rubin MA, Neuhauser MM, Gundlapalli A, et al. (2012) Drugs of Last Resort? The Use of Polymyxins and Tigecycline at US Veterans Affairs Medical Centers, 2005. PLoS ONE 7(5): e36649. doi:10.1371/journal.pone.0036649

add to favorites email to friend print save as pdf

Related Stories

'Last resort' antibiotics use on the rise, study shows

Apr 03, 2011

A large, multi-year study of antibiotic use in Veterans Health Administration's acute care facilities demonstrates dramatically increased use of carbapenems, a powerful class of antibiotics, over the last five years. These ...

Nanotechnology used to probe effectiveness of antibiotics

Feb 04, 2009

A group of researchers led by scientists from the London Centre for Nanotechnology, in collaboration with a University of Queensland researcher, have discovered a way of using tiny nano-probes to help understand how an antibiotic ...

Small amounts of antibiotics generate big problems

Jul 22, 2011

New research conducted at Uppsala University shows that extremely low concentrations of antibiotics can enrich for antibiotic resistant bacteria. The research suggests that antibiotic residue introduced to the environment ...

Antibiotic use increases at academic medical centers

Nov 10, 2008

Antibacterial drug use appears to have increased at academic medical centers between 2002 and 2006, driven primarily by greater use of broad-spectrum agents and the antibiotic vancomycin, according to a report in the Nov. ...

Recommended for you

Have a cold? Don't ask your doctor for antibiotics

3 hours ago

Antibiotic resistance is a major threat to public health. Resistance makes it harder for physicians to treat infections and can increase the chance patients will die from an infection. What is more, the treatment ...

Powdered measles vaccine found safe in early clinical trials

Nov 25, 2014

A measles vaccine made of fine dry powder and delivered with a puff of air triggered no adverse side effects in early human testing and it is likely effective, according to a paper to be published November 28 in the journal ...

Health care M&A leads global deal surge

Nov 23, 2014

In a big year for deal making, the health care industry is a standout. Large drugmakers are buying and selling businesses to control costs and deploy surplus cash. A rising stock market, tax strategies and ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.